Abatacept inhibits Th17 differentiation and mitigates α-synuclein-induced dopaminergic dysfunction in mice.
Clarke JR, Bacelar TS, Fernandes GG, Silva RCD, Antonio LS, Queiroz M, de Souza RV, Valadão LF, Ribeiro GS, De Lima EV, Colodeti LC, Mangeth LC, Wiecikowski A, da Silva TN, Paula-Neto HA, da Costa R, Cordeiro Y, Passos GF, Figueiredo CP.
Clarke JR, et al.
Mol Psychiatry. 2024 Aug 16. doi: 10.1038/s41380-024-02618-1. Online ahead of print.
Mol Psychiatry. 2024.
PMID: 39152331